Cargando…
Remdesivir-Induced Liver Injury in a Patient With Coronavirus Disease 2019 and History of Congestive Hepatopathy
Remdesivir is an antiviral agent used as supportive care in adults with SARS-COV2-induced pneumonia. We report a case of an 81-year-old patient who developed hepatocellular acute liver injury 48 hours after initiating remdesivir. During the investigation, other causes of hepatotoxicity were excluded...
Autores principales: | Dividis, Georgios P, Papadopoulos, Georgios E, Karageorgiou, Ioannis, Kotronis, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733800/ https://www.ncbi.nlm.nih.gov/pubmed/36514704 http://dx.doi.org/10.7759/cureus.32353 |
Ejemplares similares
-
Congestive Hepatopathy
por: Fortea, José Ignacio, et al.
Publicado: (2020) -
Acute Liver Failure From Sickle Cell Hepatopathy Treated With Exchange Transfusion
por: Kassem, Ahmad N, et al.
Publicado: (2021) -
Duodenal Fibrosis Mimicking Neoplastic Obstructive Hepatopathy in the Setting of Lynch Syndrome
por: Hernandez, Oscar L, et al.
Publicado: (2023) -
Glycogen Hepatopathy: A Reversible yet Relapsing Cause of Hepatitis in Type 1 Diabetics
por: Azhar, Mishah, et al.
Publicado: (2021) -
Combined heart-liver transplantation for congestive hepatopathy with bridging fibrosis: Is it warranted?
por: Izzy, Manhal, et al.
Publicado: (2021)